Penumbra PEN
NYSE PEN
$323.91 -2.97 (-0.91%)
At close: Aug 20, 2026 · 4:00 PM EDT

Penumbra (PEN) Cash from Investing Activities (2014 - 2026)

Penumbra (PEN) posted quarterly Cash from Investing Activities of -$91.1 million for Q2 2026, down 484.67% year-over-year from $23.7 million in Q2 2025, and down 197.36% quarter-over-quarter from -$30.6 million in Q1 2026.

Penumbra (PEN) Cash from Investing Activities (2014 - 2026) Analysis & Trends

Penumbra (PEN) has reported Cash from Investing Activities for 13 consecutive years, with -$91.1 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Cash from Investing Activities fell 484.67% year-over-year to -$91.1 million; the TTM figure through Jun 2026 stood at -$510.2 million (down 5975.54% YoY), while the FY2025 annual figure was -$404.6 million, down 621.22% from the prior year.
  • Cash from Investing Activities fell to -$91.1 million in Q2 2026 per PEN's latest filing, from -$30.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $35.7 million in Q3 2024 and bottomed at -$225.6 million in Q4 2025.
  • Historically, Cash from Investing Activities has averaged -$22.8 million across 5 years, with a median of $4.1 million in 2022.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 744.73% — and 2026, when it tumbled 6002.19%.
  • Penumbra's Cash from Investing Activities stood at $8.6 million in 2022, then jumped by 181.25% to $24.3 million in 2023, then tumbled by 145.12% to -$11.0 million in 2024, then slumped by 1959.76% to -$225.6 million in 2025, then surged by 59.63% to -$91.1 million in 2026.
  • Business Quant data shows PEN's Cash from Investing Activities at -$91.1 million in Q2 2026, -$30.6 million in Q1 2026, and -$225.6 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -673.00 Mn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -639.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -193.20 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -22.08 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -108.50 Mn
10 Penumbra 12.76 Bn 12.10 Bn 264.94 Mn -91.09 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -91.09 Mn
Jun 30, 2026 -91.09 Mn
Mar 31, 2026 -30.63 Mn
Mar 31, 2026 -30.63 Mn
Dec 31, 2025 -225.65 Mn
Dec 31, 2025 -225.65 Mn
Sep 30, 2025 -162.86 Mn
Sep 30, 2025 -162.86 Mn
Jun 30, 2025 -15.58 Mn
Jun 30, 2025 -15.58 Mn
Mar 31, 2025 -502,000.00
Mar 31, 2025 -502,000.00
Dec 31, 2024 -10.96 Mn
Dec 31, 2024 -10.96 Mn
Sep 30, 2024 35.72 Mn
Sep 30, 2024 35.72 Mn
Jun 30, 2024 34.47 Mn
Jun 30, 2024 34.47 Mn
Mar 31, 2024 18.38 Mn
Mar 31, 2024 18.38 Mn